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Cystic Fibrosis Patient during
Chronic Infection
Ana S. Moreira, Artur B. Lourenço† and Isabel Sá-Correia*
Department of Bioengineering, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de
Lisboa (ULISBOA), Lisbon, Portugal
During cystic fibrosis (CF) chronic lung infections, bacteria of the Burkholderia
cepacia complex (Bcc) are exposed for several years to a stressful and changing
environment. These environmental challenges results in genetic changes of the initial
infecting strain with the consequent diversification of genotypes and phenotypes.
The exploitation of functional and comparative genomic approaches has suggested
that such diversification is associated with massive metabolic remodeling but these
alterations are poorly understood. In the present work, we have explored a high
resolution 1H-NMR-based metabolomic approach coupled to multivariate analysis to
compare the endometabolome of three B. cenocepacia clonal variants retrieved from a
CF patient from the onset of infection (IST439) until death with cepacia syndrome after
3.5 years (IST4113 and IST4134), to complement former proteomic and transcriptomic
analyses. A fourth clonal variant (IST4129) retrieved from the same CF patient when
the clinical condition worsened during the last months of life, was also examined
since it was found to lack the third replicon. The metabolomic profiles obtained,
based on the complete 1H-NMR spectra, highlight the separation of the four clonal
variants examined, the most distinct profile corresponding to IST4129. Results indicate
a variable content of several amino acids in the different isolates examined and suggest
that glycolysis and the glyoxylate shunt are favored in late variants. Moreover, the
concentration of two metabolites with demonstrated cellular protective functions against
stress, glycine-betaine and trehalose, is different in the different isolates examined.
However, no clear correlation could be established between their content and stress
tolerance. For example, IST4113, previously found to be the most resistant variant to
antimicrobials of different classes, exhibits low levels of trehalose and glycine-betaine
but the highest resistance to heat and oxidative stress. Also, IST4129, with a high
level of glycine-betaine but lacking the third replicon, previously associated with stress
resistance and virulence, exhibits the highest susceptibility to all the stresses tested.
Taken together, results from this study provide insights into the metabolic diversification
of B. cenocepacia clonal variants during long-term infection of the CF airways.
Keywords: Burkholderia cepacia complex, 1H-NMR based metabolomics, cystic fibrosis, chronic respiratory
infection, stress tolerance, clonal variation, trehalose, glycine-betaine
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INTRODUCTION
Cystic fibrosis (CF) chronic lung infections caused by
Burkholderia cepacia complex (Bcc) bacteria are usually
associated with a rapid decline in lung function and decreased
life expectancy (Mahenthiralingam et al., 2005; Lipuma, 2010).
Once inside the CF lung, Bcc bacteria face a changing and
stressful environment resulting from the activity of the host
immune system, antimicrobial therapy, fluctuating levels of
nutrients, decreasing oxygen availability and the presence of
other co-infecting microbes (Döring et al., 2011). As proposed
for Pseudomonas aeruginosa (Smith et al., 2006; Clark et al.,
2015; Marvig et al., 2015), it is believed that these challenging
environmental conditions stimulate genetic alterations in the
initial infecting strain, leading to the diversification of genotypes
and phenotypes and to the emergence of multiple clonal variants
from the underlying Bcc population (Coutinho et al., 2011a,b;
Lieberman et al., 2011, 2014; Moreira et al., 2014; Zlosnik et al.,
2014; Miller et al., 2015; Maldonado et al., 2016).
The genome sequence and expression alterations experienced
by Bcc bacteria during chronic infections have recently been
on the focus of several studies. The genome sequences of
late Burkholderia cenocepacia isolates retrieved from a CF
patient after 10 years of chronic infection were compared with
the initial infecting strain and mutations in genes involved
in metabolism, including genes from amino acid, iron and
purine metabolism, were identified (Miller et al., 2015). Another
comparative genomic study focusing on B. multivorans isolates
retrieved from a CF patient over 20 years of infection has shown
that genes involved in gene expression regulation, cell envelope
biogenesis, fatty acid and amino acid metabolism exhibit
recurrent mutation patterns (Silva et al., 2016). Comparative
genomic analysis of 112 B. dolosa isolates retrieved from 14
CF patients over 16 years of epidemic outbreak suggested that
genes involved in secretion, outer membrane synthesis, oxygen-
dependent regulation and antibiotic resistance are under strong
selective pressure (Lieberman et al., 2011). Non-synonymous
mutations in other genes involved in central metabolism were
also detected, including five mutations in genes coding for
three components of the 2-oxoglutarate dehydrogenase complex
(Lieberman et al., 2011); two of these genes were also found
to be mutated in a B. cenocepacia biofilm community after
more than 1000 generations of selection (Traverse et al., 2013).
The importance of cellular metabolism in Bcc persistence and
pathogenesis was further supported by the demonstration of the
crucial role of 21 metabolism-related genes in B. cenocepacia
K56-2 survival (Hunt et al., 2004). Moreover, the comparison of
genomic expression analyses based on quantitative proteomics
and transcriptomics of three B. cenocepacia clonal variants
retrieved from the same chronically infected CF patient during
3.5 years is also consistent with metabolism diversification
Abbreviation: Bcc, Burkholderia cepacia complex; CF, cystic fibrosis; CPMG, Carr-
Purcell-Meiboom-Gill; d4-TSP, trimethylsilyl-2,2,3,3-tetradeuteropropionate; 1H-
NMR, proton nuclear magnetic resonance; HSM, Hospital de Santa Maria;
O-PLS-DA, orthogonal partial least squares discriminant analysis; PCA, principal
component analysis; ROS, reactive oxygen species; TCA, tricarboxylic acid cycle;
VIP, variable importance projection.
during chronic CF lung infection (Coutinho et al., 2011a,b;
Madeira et al., 2011, 2013; Mira et al., 2011). The three isolates
examined in these genome-wide expression analyses include the
first and the last isolates retrieved from the patient before death
with the cepacia syndrome (IST439 and IST4134, respectively),
and one intermediate isolate exhibiting a high resistance to
several antimicrobial of different classes, retrieved after a period
of exacerbated pulmonary function and intravenous therapy,
IST4113. Several genes and proteins found to exhibit an altered
expression in the two late isolates compared with the first isolate
are involved in amino acid, purine, pyrimidine, tricarboxylic acid
(TCA) cycle, glycolysis/gluconeogenesis, pyruvate metabolism,
and oxidative phosphorylation. Taken together, these reports
suggest a relevant role for metabolic reprogramming during Bcc
persistence in the CF lung, even though the specific metabolic
changes occurring along CF chronic lung infection are still poorly
characterized.
Metabolomic approaches are of uttermost importance since
metabolites are further down the line from gene to function,
reflecting more closely the cellular activity at a functional level.
However, studies involving this type of analysis are scarce, though
the usefulness of a metabolomic approach for the understanding
of bacterial metabolic adaptation was already demonstrated
through the analysis of the osmotic stress effect in B. cenocepacia
clinical isolates (Behrends et al., 2011) and the metabolomic
footprinting of 179 P. aeruginosa isolates retrieved from several
CF patients (Behrends et al., 2013). In the present work, we
have performed an endometabolomic analysis of the three above
referred B. cenocepacia clonal isolates (IST439, IST4113 and
IST4134) whose genome-wide expression analysis was previously
examined in our laboratory. This metabolomics analysis was
based on 1H-NMR aiming to unveil the alterations occurring in
the metabolome of these B. cenocepacia clonal variants during
a chronic infection. This comparative analysis was extended
to a fourth clonal variant (IST4129) retrieved from the same
CF patient 3 months before death with the cepacia syndrome
when the clinical condition worsened, given that it was found
to lack the third replicon (Moreira et al., 2016). This replicon
is required for virulence, tolerance to multiple stresses, D-xylose,
pyrimidine and fatty acid utilization, as well as exopolysaccharide
production and protease activity in some strains (Agnoli et al.,
2012, 2014). Moreover, from the 776 predicted coding sequences
of the B. cenocepacia J2315 third replicon, a high percentage
corresponds to hypothetical proteins and genes with unknown
function (Holden et al., 2009). Since our goal was to compare
the data gathered in the present work for four previously
characterized clonal variants (Cunha et al., 2003; Coutinho
et al., 2011a; Moreira et al., 2016) retrieved from the same
patient during chronic infection with the information previously
obtained using other genome-wide expression approaches, cells
were grown under conditions identical to those tested before
and though to mimic those expected to occur during growth
in the CF lung (Madeira et al., 2011, 2013; Mira et al., 2011).
Although static measurement of metabolite pool sizes cannot be
used to infer about metabolic fluxes, the observed changes may
indicate potential alterations in pathway activity (Nandakumar
et al., 2014). To the best of our knowledge, this is the first study
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using an endometabolomic approach coupled to multivariate
statistical analysis to get insights into the metabolic diversity of
B. cenocepacia during chronic infection of the CF airways.
MATERIALS AND METHODS
Bacterial Isolates and Growth Conditions
The four Burkholderia cenocepacia clonal variants examined
in this study, IST439, IST4113, IST4129 and IST4134, were
recovered from the sputum of a CF patient under surveillance
at the major Portuguese CF Center in the Hospital de Santa
Maria from Centro Hospitalar Lisboa Norte EPE, Lisbon, from
January 1999 to July 2002, as part of the hospital routine (Cunha
et al., 2003; Coutinho et al., 2011a; Moreira et al., 2016). For
each isolation date, one well isolated colony capable of growing
onto the selective B. cepacia Selectatab medium was picked at
random. Bacterial growth was carried out in Lysogeny Broth,
Lennox (LB; Conda, Pronadisa), at 37◦C and 250 rpm, or in
LB agar plates obtained by supplementation of LB with 2% agar
(Iberagar, Portugal).
Endometabolome Profiling
Cell Sampling and Metabolite Extraction
B. cenocepacia isolates were grown in LB broth until mid-
exponential phase (OD640 nm of 0.4 ± 0.04). After dilution to a
standardized OD640 nm of 0.2 ± 0.02 in 0.9% NaCl (w/v), 100 µl
of these cell suspensions were plated onto plates containing
30 ml of LB agar and then incubated for 24 h at 37◦C. These
growth conditions mimic those previously used to obtain cells
to perform genome-wide expression analyses dedicated to three
of the B. cenocepacia clonal isolates examined during the present
study (Madeira et al., 2011, 2013; Mira et al., 2011), as well as
the surface-attached growth expected to occur in the CF lung
(Coutinho et al., 2011b; Madeira et al., 2011). Cells were washed
from plates with 3 ml of 0.9% NaCl (w/v) and collected by
centrifugation at 4500 × g, 4◦C, during 10 min. The pellet was
washed with 5 ml of 0.9% NaCl (w/v) and centrifuged again. One
and a half ml of glass beads (0.4–0.6 mm diameter) and 9 ml of
ethanol/water (75:25 v/v) heated to 80◦C in a water bath were
added to the pellets. The mixture was vortexed for 30 s, heated
for 3 min to 80◦C, vortexed again for 30 s and pelleted in a
centrifuge cooled to −10◦C (4500 × g, 10 min). The supernatant
was transferred to a new tube and the extraction step was repeated
with 6 ml of ethanol (75:25 v/v). The supernatants were mixed,
cleared by centrifugation (10000 × g, −10◦C, 10 min), dried
under vacuum and stored at −80◦C until NMR analysis. To
increase signal sensitivity and reduce biological variation, two
extracts from the same isolate and independently prepared were
mixed together, producing a single sample (Malmendal et al.,
2006; Colinet et al., 2013). For each isolate, six independent
samples were analyzed by proton-NMR.
NMR Data Acquisition, Processing and Resonance
Assignments
The dried extracts were dissolved in 1 ml of buffer (0.1 M
phosphate buffer pH 7.00 in D2O, containing 0.1 M of d4-TSP)
and transferred to 5 mm diameter NMR tubes. The samples
were analyzed using a 500 MHz Avance III Bruker spectrometer,
equipped with a 5 mm inverse probe (TXI), at 296 K, at the IST
campus (Centro de Química Estrutural, CQE). One dimensional
(1D) proton spectra were acquired using a train of CPMG
echoes, of 40 ms long, to reduce macromolecules broad signal.
All proton spectra were manually phased, baseline corrected
and referenced to d4-TSP (δ 0.00 ppm) using Mnova v7.1 for
NMR data processing. For metabolite identification purpose
Total Correlation Spectroscopy (TOCSY; 512 × 2 K data points,
relaxation delay of 2 s, mixing time of 60 ms and 64 transients
per FID), and Heteronuclear Single Quantum Coherence (HSQC;
512 × 2 K data points, relaxation delay of 1.5 s, 64 transients
per FID and a spectral width of 174 ppm in indirect dimension)
spectra were collected for representative samples. Metabolite
identity was assigned by careful analysis of chemical shifts,
intensities, J couplings and multiplicities of the peaks present
in 1D proton spectra, complemented with information from
TOCSY and HSQC spectra and data gathered from different
databases, as described previously (Lourenço et al., 2011, 2013).
The identity of each metabolite was confirmed by comparison
with spectra obtained for each authentic standard using the same
sample conditions and NMR parameters.
Multivariate Data Analysis
The methodology used herein for the analysis of the NMR
metabolic data has been extensively reviewed (Griffin, 2004;
Trygg et al., 2007; Worley and Powers, 2013). Briefly, the
spectra regions corresponding to residual water and ethanol were
excluded (5.15-4.50, 3.73-3.63, 1.26-1.14 ppm). Each spectrum
was integrated over a series of fixed width bins (0.005 ppm)
using Mnova v7.1 features and normalized to its total intensity
between 9.95 and 0.08 ppm. All spectra data were then put in
a data table form in an ASCI format file and imported into
the software SIMCA-P12+ for multivariate data analysis. The
data was pre-processed in SIMCA-P12+ using Pareto scaling.
PCA and O-PLS-DA were performed. Preliminary application of
an unsupervised method like PCA provides an informative first
look at the dataset structure and relationships between groups.
After PCA, the supervised method O-PLS-DA was used to better
discriminate between clusters evidenced by the PCA (Worley
and Powers, 2016). SIMCA-P12+ provides a model summary
table with different statistical measures for evaluating the model
quality. Namely, the Sum of Squares of all the x-variables
explained by the components (R2X), the Sum of Squares of
all the y-variables explained by the components (R2Y) for the
O-PLS-DA and the predicted power (Q2), calculated by sevenfold
internal cross-validation, of the model. The R2 and Q2 should be
similar. The value of Q2 ranges from 0 to 1 and typically a Q2
value higher than 0.4 is considered a good model, whereas if Q2
is substantially lower than R2 then the robustness of the model
is poor (Westerhuis et al., 2008; Wheelock and Wheelock, 2013)
For the O-PLS-DA modeling, a measure of the degree to which
a particular variable explains cluster membership was obtained
with the Variable Importance in the Projection (VIP) plot (with
confidence intervals derived from jack knifing routine). Variables
with VIP value above 1 are important for class membership.
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Statistical Analysis
Statistical analysis was performed using Prism GraphPad
software 6.05 (GraphPad Software, San Diego, CA, USA). To
test if the data for each isolate and metabolite has a normal
distribution, the Kolmogorov–Smirnov test was used. The
statistical significance of the differences obtained in the relative
abundance of each identified metabolite between the first isolate
(IST439) and the late isolates was calculated using unpaired two
tailed Student’s t-test for populations with Gaussian distribution,
or the Mann–Whitney test for populations without Gaussian
distribution. P≤ 0.05 was considered statistically significant. Box
and whisker plots were generated using GraphPad Prism 6.05
Software.
Comparison of the Susceptibility of the
Different B. cenocepacia Clonal Variants
to Stress Conditions
Osmotic Stress
Liquid cultures grown in LB medium at 37◦C and 250 rpm until
mid-exponential phase were used to inoculate, at an initial OD640
of 0.05, 5 ml of LB broth supplemented with additional NaCl to
a total concentration of 2 M or 3 M. Cultures were incubated
in these media at 37◦C and 250 rpm, and colony-forming units
(CFUs) were determined by plating serial dilution of these cell
suspensions in LB plates at different intervals. Results are the
mean of at least three independent experiments.
Oxidative Stress
Liquid cultures grown in LB medium at 37◦C and 250 rpm
until mid-exponential phase were used to inoculate, at an initial
OD640 of 0.05, 5 ml of LB broth supplemented with 0.01% H2O2.
Cultures were incubated in this media at 37◦C and 250 rpm, and
CFUs were determined by plating serial dilutions of these cell
suspensions in LB plates at different intervals. Results are the
mean of at least three independent experiments.
Heat Stress
Liquid cultures grown in LB medium at 37◦C and 250 rpm until
mid-exponential phase were used to inoculate, at an initial OD640
of 0.05, 5 ml of LB broth. Cultures were incubated at 42◦C or 44◦C
at 250 rpm, and CFUs were determined by plating serial dilutions
of these cell suspensions in LB plates at different intervals. Results
are the mean of at least three independent experiments.
Ethics
Research studies involving the clinical Bcc isolates examined in
this study and obtained as part of the HSM routine were approved
by the hospital ethics committee and the patient’s anonymity is
preserved.
RESULTS
Alterations in the Endometabolome of
Burkholderia cenocepacia Clonal
Isolates Retrieved during Chronic
Infection
The 1H-NMR spectra acquired from extracts obtained from
B. cenocepacia cells grown 24 h at 37◦C onto the surface of LB
agar medium allowed the detection of hundreds of resonances
(Figure 1). Several classes of biomolecules were identified,
FIGURE 1 | Representative endo-metabolome profiles. High resolution 1H NMR spectra from the endometabolomes of B. cenocepacia sequential clonal
variants retrieved from a CF patient chronically colonized for 3.5 years. Spectra are representative of all the replicates obtained for each isolate and were normalized
to the reference, TSP (δ = 0.0 ppm).
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including amino acids (L-alanine, L-valine, L-methionine, L-
serine, glycine, L-glutamic acid, L-glutamine, L-aspartic acid,
L-tyrosine, L-phenylalanine), osmolytes (trehalose and glycine-
betaine), cofactors (NADH and NAD+), organic acids (acetic,
fumaric and succinic acids), and metabolites associated with
energy metabolism (ADP and AMP) (Figure 1, Supplementary
Table S1).
Modulation of the endometabolome data using PCA
generated a model with four principal components (PCs)
(R2X = 0.911 and Q2 = 0.862) (Figure 2A). The different
biological replicates were grouped in four distinct clusters, which
correspond to the four isolates under analysis, IST439, IST4113,
IST4129 and IST4134 (Figures 2A,C). The analysis of both
the score plot and dendrogram shows that the most distinct
metabolic profile belongs to IST4129. Further analysis of this data
using Orthogonal-Partial Least Squares-Discriminant Analysis
(O-PLS-DA), and in accordance with the PCA modeling, clearly
distinguished the different isolates under study (Supplementary
Table S2), indicating that each of the four isolates is metabolically
distinct from the others. Additionally, the loading plot reveals
that glycine-betaine, trehalose, L-methionine, L-glycine, and
L-serine were the metabolites that contributed more to cluster
separation (Figure 2B). VIP analysis showed that glycine-betaine,
trehalose, and glycine are three of the most important identified
metabolites contributing to separate IST439 from IST4113 and
IST4129, while glycine-betaine, L-valine, and succinic acid are the
three identified metabolites that contribute more to separation
between IST439 and IST4134. This analysis also revealed a
significant contribution of a still unidentified metabolite, at
2.18 ppm, for separation between IST439 and IST4113.
Overall, no isolation time-dependent pattern of alteration
in the relative abundance of several metabolites was identified
(Figures 3 and 4). However, late isolates IST4129 and IST4134
showed higher levels of L-alanine, L-valine, L-tyrosine, L-aspartic
acid, glycine-betaine, NAD+, ADP and AMP than the isolates
retrieved before from the patient. Moreover, the levels of
succinic acid and L-glutamic acid were higher in the first
isolate retrieved from the patient, compared with the three late
isolates. A metabolite-to-metabolite correlation analysis of the
endometabolome data from each late isolate and isolate IST439
suggested that some metabolite concentration changes may be
linked, namely succinic acid with L-glutamate, NAD+ with
glycine-betaine, L-tyrosine and L-leucine, though with different
R2 values (Supplementary Figure S1).
Comparison of B. cenocepacia Clonal
Variants Tolerance to Multiple Stresses
Since glycine-betaine and trehalose levels were found to exhibit
significant differences between the B. cenocepacia clonal variants
examined (Figure 4) we have compared the ability that the
different variants grown in the absence of stress have to survive
to sudden exposure to heat, oxidative or osmotic (saline) stresses
(Figure 5). In fact, these solute compatible compounds have been
implicated in B. cenocepacia response to osmotic (saline) stress
(Behrends et al., 2011) and shown to have additional roles in
microbial protection against temperature and oxidative stress
FIGURE 2 | Endometabolome multivariate analysis of four
B. cenocepacia sequential clonal variants retrieved from a CF patient
chronically infected for 3.5 years. (A) 2D score plot displaying the space
formed by the two first principal components (R2X for PC1 equal to 0.693 and
R2X for PC2 equal to 0.139), (B) 2D loading plot displaying the space formed
by the two first principal components and displaying the characteristic bins for
a set of metabolites, and (C) dendrogram based on the PCA scores (ward
clustering distance measure) considering all principal components of the
model. For the 2D score plot shown in (A), each point represents a spectra
obtained for independent samples, resulting in six samples for each isolate.
Key: (1) Trehalose, (2) Glycine, (3) L-serine, (4) Glucose, (5) Uracil, (6)
Fumarate, (7) L-aspartic acid, (8) Oxidized glutathione, (9) AMP, (10) L-alanine,
(11) NAD+, (12) L-valine, (13) ADP, (14) L-tyrosine, (15) NADP+, (16) Succinic
acid, (17) L-glutamic acid, (18) L-phenylalanine, (19) NADH, (20) L-methionine,
and (21) Glycine-betaine.
(Caldas et al., 1999; Canovas et al., 2001; Alvarez-Peral et al., 2002;
Liu et al., 2011; Pilonieta et al., 2012).
In general, isolate IST4129, lacking the third replicon
previously described as being involved in resistance to multiple
stresses (Agnoli et al., 2014) but exhibiting the highest abundance
of glycine-betaine and the lowest abundance of trehalose, was
found to be the most susceptible clonal isolate to all the
stresses tested (Figure 5). However, a slightly higher tolerance
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FIGURE 3 | Relative abundance of the amino acids detected through the comparative analysis of the endometabolomes of four B. cenocepacia
sequential clonal variants retrieved from a CF patient chronically infected for 3.5 years. Each plot shows the variation of the relative abundance of a
representative bin in all the spectra for each metabolite and B. cenocepacia isolate. Median values are represented by the line in the middle of the box with the ends
showing the 25th and 75th percentiles. Upper and lower ends of the lines represent the maximum and minimum values respectively. ∗P < 0.05 when each late
B. cenocepacia isolate was compared to the first isolate, IST439.
was apparently observed during the first 10 min following
sudden exposure to osmotic stress with 3M NaCl (Figure 5B).
Remarkably, whereas IST439 was the isolate with the highest
tolerance to osmotic stress (Figures 5A,B), IST4113, which
was the isolate with lowest levels of both glycine-betaine and
trehalose, exhibits the highest tolerance to heat and oxidative
stresses (Figures 5C–E).
DISCUSSION
The multivariate analysis of the metabolic profiles of the four
Burkholderia cenocepacia clonal variants examined in this work
shows that isolate IST439, the first isolate retrieved from
the patient, is metabolically closer to the last clonal variant
retrieved from the patient, IST4134, than to clonal variant
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FIGURE 4 | Relative abundance of cofactors, metabolites involved in energy metabolism, organic acids, sugars, uracil and osmolytes, detected
through comparative analysis of the endometabolomes of four B. cenocepacia sequential clonal variants retrieved from a CF patient chronically
infected for 3.5 years. Each plot shows the variation of the relative abundance of a representative bin in all the spectra for each metabolite and B. cenocepacia
isolate. Median values are represented by the line in the middle of the box with the ends showing the 25th and 75th percentiles. Upper and lower ends of the lines
represent the maximum and minimum values respectively. ∗P < 0.05 when each late B. cenocepacia isolate was compared to the first isolate, IST439.
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FIGURE 5 | Effect of different stresses in the viability of the cultures of four B. cenocepacia sequential clonal variants examined. Cultures of the four
isolates under study, IST439 (N), IST4113 (), IST4129 () and IST4134 ( ) cultivated in the absence of stress were exposed to different stresses, namely osmotic
(saline) stress using 2M NaCl (A) or 3M NaCl (B), heat stress at 42◦C (C) or 44◦C (D), and oxidative stress using 0.01% hydrogen peroxide (E). Error bars represent
standard deviation.
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IST4113 retrieved 9 months before the patient’s death and
previously found to be remarkably resistant to antimicrobials
of different classes (Coutinho et al., 2011a). Consistent with
this conclusion is the expression proteomic data previously
obtained for isolates IST4113 and IST4134 that also indicates
that the number of proteins exhibiting different content in
IST439 compared with the two late isolates is lower for
IST4134 than for IST4113, with several proteins showing an
altered content in IST4113, but not in IST4134, compared to
IST439 (Madeira et al., 2013). The endometabolome profile
analysis also showed that the clonal variant IST4129 lacking
the third replicon (Moreira et al., 2016), exhibits the most
distinct metabolic profile. Even though IST4129 and IST4134
were retrieved in the last stages of the illness at isolation dates
separated by only 9 months (Coutinho et al., 2011a), it is
intriguing why the loss of such a large genomic element in
IST4129 does not significantly change the relative abundances
of several of the metabolites that were identified in these
isolates. However, this appears to be consistent with the
conclusions from a previous transcriptomic analysis comparing
B. cenocepacia H111 with the derived mutant lacking the
third replicon that has shown that only one half of the
third replicon genes are expressed in LB medium and only a
few genes from chromosomes 1 and 2 are regulated by this
megaplasmid (Agnoli et al., 2012). Moreover, the megaplasmid
is essentially required for secondary metabolism, virulence and
stress resistance of Bcc bacteria although a large percentage of
the encoded genes are of unknown function (Holden et al.,
2009; Agnoli et al., 2012, 2014). Our data also reinforce
the idea that core functions, such as energy and central
metabolism are not significantly affected by the loss of the third
replicon and suggest that the separation between IST4129 and
the other isolates based on multivariate analysis results from
differences in parts of the spectra related with still unidentified
metabolites (e.g., singlet at 3.905 or a doublet of doublets at
7.96).
Results from the identified changes occurring in the
endometabolome of B. cenocepacia clonal variants retrieved from
a CF patient chronically infected during 3.5-years, from the
onset of the infection until death with the cepacia syndrome,
are summarized in Figure 6. Marked differences in the level
of the pyridine nucleotides NADH and NAD+ were observed
between the first isolate retrieved from the patient and the
late isolates IST4129 and IST4134. Since these cofactors are
the most important redox carriers involved in metabolism,
acting as electron acceptors in catabolic processes and providing
the necessary reducing power for energy-producing redox
reactions, having been proposed as involved in more than 120
reactions throughout B. cenocepacia metabolism (Fang et al.,
2011; Bartell et al., 2014), it is tempting to speculate that
the altered redox status of these isolates might contribute
to several of the metabolite differences observed. Among
the alternative pathways that can be used in the turnover
of NAD+ to NADH is the biosynthesis of glycine-betaine,
L-tyrosine and L-leucine from betaine aldehyde, chorismate
and valine, respectively (Bartell et al., 2014). Remarkably, the
relative abundance of glycine-betaine, L-tyrosine and L-leucine
is higher in IST4129 and IST4134 compared with IST439.
Differently, isolate IST4113 has a lower NAD+ and NADH
content compared with IST439 but for NADH the difference is
not statistically significant. In fact, the NADH/NAD+ ratio in
IST4113 is not clearly distinct from the same ratio in IST439,
as observed for several other changes found between the first
isolate and the late isolates IST4129 and IST4134 but not for
IST4113.
A reduction in the NADH/NAD+ ratio was registered in
isolates IST4129 and IST4134 compared to the first isolate
IST439, particularly due to the higher abundance of NAD+.
In Escherichia coli, a low NADH/NAD+ ratio was shown to
favor the metabolic flux toward the pyruvate dehydrogenase
complex (PDHc) (de Graef et al., 1999), consistent with the
upregulation of the expression of PDHc and several proteins
involved in TCA registered in the late isolate IST4134 compared
to IST439, as indicated by a previous expression proteomic
analysis (Madeira et al., 2013). Also, the higher levels of fumaric
acid and of the amino acid L-aspartate, derived from the
intermediate of TCA cycle oxaloacetate, in both IST4129 and
IST4134, suggest that the metabolism through glycolysis and
TCA might be favored in these late isolates compared with the
first isolate. The adaptation of Pseudomonas aeruginosa to the
CF lung environment was previously proposed to occur through
significant metabolic changes that include increased expression
of genes involved in the TCA cycle and a reduction in acetate
excretion, presumably resulting from changes that favor a more
efficient utilization of carbon substrates and, consequently, a
higher metabolic fitness in the CF lung environment (Hoboth
et al., 2009; Behrends et al., 2013). The changes found in our
study in late B. cenocepacia clonal variants IST4129 and IST4134
may presumably reflect a similar adaptive response to the CF lung
environment.
An intriguing result was obtained for succinic acid, whose
abundance is lower in all the late isolates compared to IST439,
with no correlation with the level of the other identified
intermediate of the TCA cycle or with L-aspartic acid. However,
a similar trend could be observed for L-glutamic acid, an
amino acid that can be synthesized from 2-oxoglutarate in a
reversible reaction using the enzyme glutamate dehydrogenase
(BCAL3359), whose expression is down-regulated in IST4113
compared to IST439 (Mira et al., 2011). Also, in the late
isolates IST4113 and IST4134 retrieved from the patient, there
is an increase in the expression of the enzymes involved in
the glyoxylate shunt (Madeira et al., 2011, 2013; Mira et al.,
2011), an anaplerotic pathway of the TCA cycle that allows
bacterial growth using acetate or fatty acids as carbon source
(Berg et al., 2002). These results suggest that the metabolic
flux is diverted from the decarboxylating steps of the TCA to
the glyoxylate shunt in late B. cenocepacia isolates. Remarkably,
2-oxoglutarate dehydrogenase, an enzyme that catalyzes the
conversion of 2-oxoglutarate into succinyl-CoA in the TCA cycle,
was previously found to be under strong selection pressure,
either during adaptation of a single biofilm community of
B. cenocepacia by more than one thousand generations of
selection (Traverse et al., 2013) or in a retrospective study of
a B. dolosa outbreak among CF patients that included 112
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FIGURE 6 | Integrative and schematic overview of the metabolite changes detected in B. cenocepacia clonal isolates retrieved from the same CF
patient. Statistically significant changes in the identified metabolites that were observed (white, gray, and black arrows) or not (white, gray, and black boxes)
between the first isolate retrieved from the patient, IST439, and the late isolates IST4113 (white symbols), IST4129 (gray symbols) and IST4134 (black symbols) are
shown (see key at the top left of the figure). The locus name of some of the genes and proteins with altered content in at least one of the late isolates compared with
IST439 are also shown. This metabolic scheme was based on information gathered from KEGG PATHWAY Database (http://www.genome.jp/kegg/pathway.html), in
BioCyc Database Collection (http://biocyc.org/) and in the metabolic reconstruction of B. cenocepacia J2315 (Bartell et al., 2014).
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isolates collected over 16 years (Lieberman et al., 2011). The
upregulation of the glyoxylate shunt was already reported to
occur in late P. aeruginosa isolates retrieved from CF patients
(Hoboth et al., 2009), and suggests the prevalence of metabolism
of acetyl-CoA produced by β-oxidation from lipids in late Bcc
and P. aeruginosa isolates. Remarkably, it was reported that
blocking the TCA cycle in its decarboxylation steps results in
increased E. coli survival to ampicillin exposure due to the
reduction of the levels of reactive oxygen species (ROS) formed
through a rapid NADH consumption after antibiotic treatment
(Kohanski et al., 2007). The involvement of isocitrate lyase,
the first enzyme of the glyoxylate cycle, in the Mycobacterium
tuberculosis resistance to three clinically used tuberculosis drugs
(isoniazid, rifampicin and streptomycin) was also demonstrated
(Nandakumar et al., 2014) and the inhibition of this enzyme was
shown to reduce the survival of B. cenocepacia persister cells
in biofilms after treatment with tobramycin, a ROS-producing
antibiotic (Van Acker et al., 2013). These results suggest that the
upregulation of the glyoxylate shunt might limit the production
of NADH through the bypass of the decarboxylating steps of
the TCA and, consequently, the production of ROS in the late
B. cenocepacia isolates under study. This can act as a protective
mechanism against the antimicrobial therapy administered to
the patient. Consistent with this hypothesis is the fact that the
late B. cenocepacia isolates IST4113, IST4129 and IST4134 are
more resistant to tobramycin than IST439 (Coutinho et al.,
2011a) and that tobramycin was found to induce bacterial
cell death through the production of ROS (Van Acker et al.,
2013).
The high availability of amino acids in the CF sputum was
proposed to represent a potential driving force for bacterial
adaptation to the lung environment (Thomas et al., 2000; Schwab
et al., 2014). Consistent with this proposal is the fact that
several studies report the emergence of CF isolates of Bcc and
P. aeruginosa that are auxotrophic for specific amino acids (Barth
and Pitt, 1995a,b; Thomas et al., 2000) and distinct lineages of
late P. aeruginosa isolates were shown to use more efficiently
amino acids with higher biosynthetic cost than early isolates
(Behrends et al., 2013). Results from the present work reveal
changes in the pool of several amino acids between the sequential
B. cenocepacia isolates, but no association with their metabolic
cost could be established since the differences observed likely
result from a balance between catabolism and anabolism of
each amino acid rather than essentially from differences in the
ability of each isolate to uptake amino acids from the medium
and metabolize them. Also, late isolates are not amino acid
auxotrophs since their growth curves are similar when grown in
the basal-mineral M9 medium, lacking amino acids (unpublished
data).
Although the metabolomic analysis here described was not
performed under stress conditions, metabolites with a described
protective function against stress were identified as having
different abundances in the B. cenocepacia clonal variants under
study. Two of these metabolites, glycine-betaine and trehalose,
were implicated in B. cenocepacia protection against osmotic
stress (Behrends et al., 2011). Additional roles of these compatible
solutes in protection against temperature and oxidative stress
were also described in other microorganisms (Caldas et al.,
1999; Canovas et al., 2001; Alvarez-Peral et al., 2002; Liu et al.,
2011; Pilonieta et al., 2012). However, results from this study
did not indicate a clear correlation between the abundance of
glycine-betaine and/or trehalose with B. cenocepacia tolerance
against various stresses, including osmotic stress, even during
early exposure to stress of cells grown in its absence. For
example, given the low abundance of both trehalose and
glycine-betaine in isolate IST4113, it was expected that it could
exhibit a higher susceptibility to several stresses. However,
this was the isolate with the highest resistance to oxidative
and heat-induced stresses. Increased resistance to oxidative
stress might be an important for Bcc survival during CF lung
infection since this environment is characterized by increased
ROS production by polymorphonuclear leukocytes (PMNs) and
impaired antioxidant protection (Roum et al., 1993; Hull et al.,
1997). Remarkably, IST4113 was the clonal variant retrieved from
this patient with the highest resistance to all the antimicrobials
previously tested (Coutinho et al., 2011a), some of which are
known to induce oxidative stress (Kohanski et al., 2007; Van
Acker et al., 2013). It is thus likely that this isolate may exhibit
a higher resistance to oxidative stress due to mechanisms of
ROS detoxification that do not involve trehalose or glycine-
betaine. Additionally, the upregulation of the glyoxylate shunt in
this isolate, already suggested by quantitative proteomic analysis
(Madeira et al., 2011) and further supported by the metabolomic
data obtained in this work, may contribute to increased resistance
of this isolate to oxidative stress and antimicrobials due to
decreased ROS generation. Other mechanisms unraveled by
proteomic and transcriptomic analyses were already implied
in the higher antimicrobial resistance of IST4113 compared
to IST439, including a higher expression of proteins/genes
involved in protein synthesis, translation, protein folding as
well as multidrug eﬄux pumps, and a lower expression of
porins in this late isolate (Madeira et al., 2011; Mira et al.,
2011). Another remarkable result concerns isolate IST4129,
which exhibits the highest level of glycine-betaine but also
the highest susceptibility to all the tested stresses. However,
since this isolate lacks the third replicon, a genomic element
previously shown to be essential for stress resistance (Agnoli
et al., 2014), its higher susceptibility to stress is not unlikely. The
in vivo loss of this third replicon is a rare event (Agnoli et al.,
2014; Moreira et al., 2016), and the loss of this megaplasmid
involved in stress resistance, virulence and secondary metabolism
is not expected to confer any advantage in the highly stressful
CF environment. Thus, it is tempting to speculate that the
higher abundance of glycine-betaine in isolate IST4129 could
be a competitive factor contributing to the persistence of this
clonal variant in the CF airways and, consequently, to its
isolation.
CONCLUSION
These results provide interesting insights into the metabolic
versatility and diversity of B. cenocepacia clonal variants and
reinforce the concept that B. cenocepacia diversify and adjusts
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metabolism when exposed to this challenging host environment
during chronic lung infection in CF patients. However, these
results should be interpreted with caution. Several recent papers
are supporting the idea of the occurrence of a high Bcc
phenotypic and genotypic diversity within a CF patient, where
multiple lineages coexist presumably as the result of bacterial
exposure to the dynamic CF lung environment during chronic
infection (Coutinho et al., 2011a; Lieberman et al., 2014; Moreira
et al., 2014, 2016; Miller et al., 2015). However, the B. cenocepacia
clonal isolates examined in this work may not be representative
of the expected population heterogeneity actually present at
each isolation time in the CF airways. Only the extension
of this metabolomic analysis to other Bcc clonal variants,
strains and CF patients may provide more definitive conclusions
concerning metabolic diversification and adaptive adjustment of
B. cenocepacia to the CF lung during long term infections.
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